Beverly A. Heinz

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

2-Amino-3-substituted-6-[(<i>E</i>)-1-phenyl-2-(<i>N</i>-methylcarbamoyl)vinyl]imidazo[1,2-<i>a</i>]pyridines as a Novel Class of Inhibitors of Human Rhinovirus:  Stereospecific Synthesis and Antiviral Activity

Chafiq Hamdouchi, Jesús de Blas, Mirian del Prado et al. · Journal of Medicinal Chemistry · 1998 · 276 citations

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · 2020 · 173 citations · Full text

Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase

C. Cheng Kao, Xueyong Yang, Allen D. Kline et al. · Journal of Virology · 2000 · 122 citations · Full text